LEVERAGING CURRENT MAXIMAL TUMOR DIAGNOSTICS.

N-OF-1 AND SHARED TRUNCAL TARGETS THAT DRIVE THE CANCER, TO ERADICATE 100% TUMOR CELLS.

FURTHER DEVELOPMENT INTO WIDER PATIENT POPULATIONS.